VEGF and myeloid leukemias

Arthur E. Frankel, Parkash S. Gill

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Vascular endothelial growth factor and vascular endothelial growth factor receptors participate in the growth and survival of myeloid leukemic progenitors. With the development of multiple anti-angiogenic agents, there is potential that some of these novel agents will have anti-leukemic activity. Since these agents work by mechanisms distinct from current cytotoxic chemotherapies, they may be useful both in chemoresistant leukemia patients and in combinations to improve remission rates and remission durations.

Original languageEnglish (US)
Pages (from-to)675-677
Number of pages3
JournalLeukemia Research
Issue number7
StatePublished - Jul 2004


  • Myeloid leukemias
  • VEGF

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'VEGF and myeloid leukemias'. Together they form a unique fingerprint.

Cite this